Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2988-93.

2.

Role of the mammalian target of rapamycin pathway in lentiviral vector transduction of hematopoietic stem cells.

Wang CX, Torbett BE.

Curr Opin Hematol. 2015 Jul;22(4):302-8. doi: 10.1097/MOH.0000000000000150. Review.

3.

Integration-deficient lentiviral vectors: a slow coming of age.

Wanisch K, Yáñez-Muñoz RJ.

Mol Ther. 2009 Aug;17(8):1316-32. doi: 10.1038/mt.2009.122. Review.

4.

Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor Cells.

Hoban MD, Romero Z, Cost GJ, Mendel M, Holmes M, Kohn DB.

Curr Protoc Stem Cell Biol. 2016 Feb 3;36:5B.4.1-10. doi: 10.1002/9780470151808.sc05b04s36. Review.

PMID:
26840227
5.

Lentiviral vectors for gene therapy of HIV-induced disease.

Amado RG, Chen IS.

Curr Top Microbiol Immunol. 2002;261:229-43. Review. No abstract available.

PMID:
11892250
6.

Lentiviral vectors for the gene therapy of lympho-hematological disorders.

Salmon P, Trono D.

Curr Top Microbiol Immunol. 2002;261:211-27. Review. No abstract available.

PMID:
11892249
7.

Retroviral vector interactions with hematopoietic cells.

Everson EM, Trobridge GD.

Curr Opin Virol. 2016 Aug 10;21:41-46. doi: 10.1016/j.coviro.2016.07.010. [Epub ahead of print] Review.

PMID:
27521874
Items per page

Supplemental Content

Support Center